X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TTK HEALTHCARE - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TTK HEALTHCARE ABBOTT INDIA/
TTK HEALTHCARE
 
P/E (TTM) x 40.8 16.3 250.4% View Chart
P/BV x 10.9 1.6 687.2% View Chart
Dividend Yield % 0.6 1.0 65.0%  

Financials

 ABBOTT INDIA   TTK HEALTHCARE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
TTK HEALTHCARE
Mar-19
ABBOTT INDIA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs6,1101,215 502.9%   
Low Rs3,996610 655.0%   
Sales per share (Unadj.) Rs1,552.2444.4 349.3%  
Earnings per share (Unadj.) Rs188.817.2 1,094.7%  
Cash flow per share (Unadj.) Rs196.427.6 710.9%  
Dividends per share (Unadj.) Rs55.005.00 1,100.0%  
Dividend yield (eoy) %1.10.5 198.7%  
Book value per share (Unadj.) Rs796.6177.9 447.7%  
Shares outstanding (eoy) m21.2514.13 150.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.1 158.5%   
Avg P/E ratio x26.852.9 50.6%  
P/CF ratio (eoy) x25.733.0 77.9%  
Price / Book Value ratio x6.35.1 123.7%  
Dividend payout %29.129.0 100.5%   
Avg Mkt Cap Rs m107,37612,894 832.7%   
No. of employees `0003.32.3 143.7%   
Total wages/salary Rs m3,9371,307 301.2%   
Avg. sales/employee Rs Th9,929.32,715.7 365.6%   
Avg. wages/employee Rs Th1,185.1565.3 209.6%   
Avg. net profit/employee Rs Th1,207.7105.4 1,145.8%   
INCOME DATA
Net Sales Rs m32,9856,279 525.3%  
Other income Rs m1,17078 1,509.5%   
Total revenues Rs m34,1556,356 537.3%   
Gross profit Rs m5,245496 1,058.3%  
Depreciation Rs m162147 110.4%   
Interest Rs m3834 113.0%   
Profit before tax Rs m6,215393 1,583.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203149 1,479.3%   
Profit after tax Rs m4,012244 1,646.3%  
Gross profit margin %15.97.9 201.5%  
Effective tax rate %35.437.9 93.5%   
Net profit margin %12.23.9 313.4%  
BALANCE SHEET DATA
Current assets Rs m22,6552,717 833.8%   
Current liabilities Rs m6,6811,571 425.3%   
Net working cap to sales %48.418.3 265.2%  
Current ratio x3.41.7 196.0%  
Inventory Days Days6532 201.4%  
Debtors Days Days2947 62.5%  
Net fixed assets Rs m835991 84.3%   
Share capital Rs m213141 150.4%   
"Free" reserves Rs m16,7152,373 704.4%   
Net worth Rs m16,9282,514 673.3%   
Long term debt Rs m03 0.0%   
Total assets Rs m24,1624,158 581.1%  
Interest coverage x163.712.6 1,297.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.41.5 90.4%   
Return on assets %16.86.7 251.2%  
Return on equity %23.79.7 244.5%  
Return on capital %36.916.9 218.1%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m369225 163.7%   
Fx outflow Rs m3,80771 5,353.1%   
Net fx Rs m-3,438154 -2,231.2%   
CASH FLOW
From Operations Rs m1,527173 882.1%  
From Investments Rs m-2,14897 -2,226.3%  
From Financial Activity Rs m-1,024-307 333.3%  
Net Cashflow Rs m-1,646-38 4,365.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 5.2 1.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 25.8 66.3%  
Shareholders   18,270 12,723 143.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Energy and Automobiles Stocks Drag(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.9% while the Hang Seng is up 0.2%.

Related Views on News

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 23, 2019 10:35 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS